CNC, Center for Neuroscience and Cell Biology, University of Coimbra, Cantanhede, Portugal.
Eur J Clin Invest. 2015 Jan;45 Suppl 1:44-9. doi: 10.1111/eci.12359.
Abnormal mitochondrial function has long been associated with the development and the progression of cancer. Multiple defects in the mitochondrial genome have been reported for various cancers, however the often disregarded mitochondrial epigenetic landscape provides an additional source of deregulation that may contribute to carcinogenesis.
This article reviews the current understanding of mitochondrial epigenetics and how it may relate to cancer progression and development. Relevant studies were found through electronic databases (Web of Science and PubMed).
The remarkably unexplored field of mitochondrial epigenetics has the potential to shed light on several cancer-related mitochondrial abnormalities. More studies using innovative, genome-wide sequencing technologies are highly warranted to assess whether and how altered mtDNA methylation patterns affect cancer initiation and progression.
异常的线粒体功能与癌症的发生和发展长期以来一直存在关联。已经有报道称,多种癌症中线粒体基因组存在多种缺陷,然而,人们经常忽视的线粒体表观遗传景观提供了一个额外的失调来源,可能有助于致癌作用。
本文综述了线粒体表观遗传学的最新认识,以及它与癌症进展和发展的关系。通过电子数据库(Web of Science 和 PubMed)找到了相关研究。
线粒体表观遗传学这一尚未得到充分探索的领域有可能阐明几个与癌症相关的线粒体异常。非常需要使用创新的全基因组测序技术进行更多的研究,以评估 mtDNA 甲基化模式的改变是否以及如何影响癌症的发生和发展。